Legislative record
117-HR4278FEDERALIn Committee
To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
Latest action: Referred to the Subcommittee on Health.
Voted 7/1/2021View source